Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2024

Aug 26, 2024

34519_dirs_2024-08-26_ea40d2f5-d206-463a-8c56-6a6176c7db03.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2024-08-23

Reporting Person: Tomsche David Scott (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-08-23 Common stock $0.10 per value per share D 6005 $3.55 Acquired 129611 Direct

Footnotes

F1: (1) This figure includes 6,987 shares of common stock held by immediate family members of Dr. Tomsche.